Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10023


Purpose:

The purpose of this study is to evaluate the effects of desipramine DMI maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving.


Criteria:

Please contact site for information.


Study is Available At:


Original ID:

NIDA-06234-1


NCT ID:

NCT00000212


Secondary ID:

R01DA006234


Study Acronym:


Brief Title:

IV Cocaine Abuse: A Laboratory Model - 1


Official Title:

IV Cocaine Abuse: A Laboratory Model


Overall Status:

Completed


Study Phase:

Phase 2


Genders:

Both


Minimum Age:

18 Years


Maximum Age:

45 Years


Quick Facts

Healthy Volunteers
Oversight Has DMC
Study Is FDA Regulated
Study Is Section 801
Has Expanded Access

Study Source:

New York State Psychiatric Institute


Oversight Authority:

United States: Federal Government


Reasons Why Stopped:


Study Type:

Interventional


Study Design:

Primary Purpose: Treatment


Number of Arms:

0


Number of Groups:

0


Total Enrollment:

0


Enrollment Type:


Overall Contact Information

Official Name:Richard Foltin, Ph.D.
Principal Investigator
Columbia University

Study Dates

Start Date:July 1987
Completion Date:July 1988
Completion Type:Actual
Primary Completion Date:July 1988
Primary Completion Type:Actual
Verification Date:December 2012
Last Changed Date:December 11, 2012
First Received Date:September 20, 1999

Study Outcomes

Outcome Type:Primary Outcome
Measure:Amount cocaine self-administered
Safety Issues:False
Outcome Type:Primary Outcome
Measure:Direct cocaine effects (cardiovascular, subjective
Safety Issues:False
Outcome Type:Primary Outcome
Measure:Interaction of cocaine and DMI on cardio measures
Safety Issues:False
Outcome Type:Primary Outcome
Measure:Interaction of cocaine/DMI on coc's subjective
Safety Issues:False
Outcome Type:Primary Outcome
Measure:Effects of DMI on cocaine craving
Safety Issues:False
Outcome Type:Primary Outcome
Measure:Drug use during outpatient DMI maintenance
Safety Issues:False

Study Interventions

Intervention Type:Drug
Name:Desipramine

Study Arms

There are no available Study Arms

Study Agencies

Agency Class:Other
Agency Type:Lead Sponsor
Agency Name:New York State Psychiatric Institute
Agency Class:NIH
Agency Type:Collaborator
Agency Name:National Institute on Drug Abuse (NIDA)

Sample and Retention Information

There are no available Sample and Retention Information

Study References

There are no available Study References

Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


This study is not currently recruiting Study Participants. The form below is not enabled.